Free Trial

Celcuity, Inc. (NASDAQ:CELC) Given Consensus Rating of "Buy" by Analysts

Celcuity logo with Medical background

Shares of Celcuity, Inc. (NASDAQ:CELC - Get Free Report) have earned a consensus rating of "Buy" from the six brokerages that are presently covering the company, MarketBeat reports. Five analysts have rated the stock with a buy rating and one has issued a strong buy rating on the company. The average twelve-month price target among brokers that have issued ratings on the stock in the last year is $28.40.

A number of analysts recently commented on the stock. HC Wainwright restated a "buy" rating and set a $27.00 price target on shares of Celcuity in a research note on Monday, May 19th. Needham & Company LLC restated a "buy" rating and set a $29.00 price target on shares of Celcuity in a research note on Monday, June 30th. Finally, Stifel Nicolaus began coverage on shares of Celcuity in a research note on Tuesday, July 1st. They set a "buy" rating and a $30.00 price target on the stock.

View Our Latest Stock Report on CELC

Celcuity Trading Up 0.7%

NASDAQ CELC traded up $0.10 during mid-day trading on Tuesday, reaching $13.61. 77,035 shares of the stock were exchanged, compared to its average volume of 240,680. Celcuity has a one year low of $7.57 and a one year high of $19.77. The company has a debt-to-equity ratio of 1.14, a current ratio of 6.61 and a quick ratio of 6.61. The stock has a market cap of $515.22 million, a P/E ratio of -4.49 and a beta of 0.45. The stock has a 50 day simple moving average of $11.65 and a 200-day simple moving average of $11.29.

Celcuity (NASDAQ:CELC - Get Free Report) last released its quarterly earnings results on Wednesday, May 14th. The company reported ($0.86) earnings per share for the quarter, topping the consensus estimate of ($0.95) by $0.09. On average, analysts anticipate that Celcuity will post -2.62 EPS for the current year.

Institutional Investors Weigh In On Celcuity

A number of institutional investors have recently made changes to their positions in CELC. Summit Investment Advisors Inc. boosted its stake in shares of Celcuity by 49.5% in the 4th quarter. Summit Investment Advisors Inc. now owns 3,421 shares of the company's stock valued at $45,000 after purchasing an additional 1,132 shares in the last quarter. Aquatic Capital Management LLC purchased a new stake in shares of Celcuity in the 4th quarter valued at $50,000. Focus Financial Network Inc. purchased a new stake in shares of Celcuity in the 1st quarter valued at $108,000. Perkins Capital Management Inc. purchased a new stake in shares of Celcuity in the 1st quarter valued at $115,000. Finally, GAMMA Investing LLC boosted its position in Celcuity by 1,237.4% during the 1st quarter. GAMMA Investing LLC now owns 1,324 shares of the company's stock valued at $131,000 after buying an additional 1,225 shares during the period. Hedge funds and other institutional investors own 63.33% of the company's stock.

Celcuity Company Profile

(Get Free Report

Celcuity Inc, a clinical stage biotechnology company, focuses on the development of targeted therapies for the treatment of various solid tumors in the United States. The company's CELsignia diagnostic platform uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the related targeted therapy for the treatment.

Read More

Analyst Recommendations for Celcuity (NASDAQ:CELC)

Should You Invest $1,000 in Celcuity Right Now?

Before you consider Celcuity, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Celcuity wasn't on the list.

While Celcuity currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Don’t Miss These Top 3 Defense Stocks Set To Gain
Triple-Digit Gains: These 4 Nuclear Stocks Have Even More Upside Ahead
3 Made in America Stocks Under $20 You Need to See!

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines